These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 27051274)
1. Role of glycogen synthase kinase-3β inhibitor AZD1080 in ovarian cancer. Chen S; Sun KX; Feng MX; Sang XB; Liu BL; Zhao Y Drug Des Devel Ther; 2016; 10():1225-32. PubMed ID: 27051274 [TBL] [Abstract][Full Text] [Related]
2. Effects of the GSK-3β inhibitor (2Z,3E)-6-bromoindirubin-3'-oxime upon ovarian cancer cells. Yu AS; Zhao L Tumour Biol; 2016 Apr; 37(4):4857-64. PubMed ID: 26526575 [TBL] [Abstract][Full Text] [Related]
3. The discovery of novel benzothiazinones as highly selective non-ATP competitive glycogen synthase kinase 3β inhibitors for the treatment of ovarian cancer. Gao Y; Ye DY; Zhou WC; Chu Y Eur J Med Chem; 2017 Jul; 135():370-381. PubMed ID: 28460311 [TBL] [Abstract][Full Text] [Related]
4. The role of glycogen synthase kinase-3β (GSK-3β) in endometrial carcinoma: A carcinogenesis, progression, prognosis, and target therapy marker. Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y Oncotarget; 2016 May; 7(19):27538-51. PubMed ID: 27050373 [TBL] [Abstract][Full Text] [Related]
5. Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and Eldehna WM; Al-Rashood ST; Al-Warhi T; Eskandrani RO; Alharbi A; El Kerdawy AM J Enzyme Inhib Med Chem; 2021 Dec; 36(1):270-285. PubMed ID: 33327806 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of N-alkyl or aryl substituted isoindigo derivatives as potential dual cyclin-dependent kinase 2 (CDK2)/glycogen synthase kinase 3β (GSK-3β) phosphorylation inhibitors. Zhao P; Li Y; Gao G; Wang S; Yan Y; Zhan X; Liu Z; Mao Z; Chen S; Wang L Eur J Med Chem; 2014 Oct; 86():165-74. PubMed ID: 25151579 [TBL] [Abstract][Full Text] [Related]
7. [Glycogen synthase kinase-3beta (GSK-3beta) promotes proliferation of ovarian cancer cells in vitro]. Cao Q; Feng YJ Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):804-9. PubMed ID: 17415999 [TBL] [Abstract][Full Text] [Related]
8. Benzimidazole-oxindole hybrids: A novel class of selective dual CDK2 and GSK-3β inhibitors of potent anticancer activity. Abdel-Mohsen HT; Syam YM; Abd El-Ghany MS; Abd El-Karim SS Arch Pharm (Weinheim); 2024 Oct; 357(10):e2300721. PubMed ID: 39041665 [TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of glycogen synthase kinase-3 beta at serine 9 confers cisplatin resistance in ovarian cancer cells. Cai G; Wang J; Xin X; Ke Z; Luo J Int J Oncol; 2007 Sep; 31(3):657-62. PubMed ID: 17671694 [TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells. Cao Q; Lu X; Feng YJ Cell Res; 2006 Jul; 16(7):671-7. PubMed ID: 16788573 [TBL] [Abstract][Full Text] [Related]
11. 2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulates proliferation of HAPI microglia by affecting the Akt/GSK-3β/cyclin D1 signaling pathway. Xu G; Li Y; Yoshimoto K; Wu Q; Chen G; Iwata T; Mizusawa N; Wan C; Nie X Toxicol Lett; 2014 Jan; 224(3):362-70. PubMed ID: 24231000 [TBL] [Abstract][Full Text] [Related]
13. Brazilein, a compound isolated from Caesalpinia sappan Linn., induced growth inhibition in breast cancer cells via involvement of GSK-3β/β-Catenin/cyclin D1 pathway. Tao LY; Li JY; Zhang JY Chem Biol Interact; 2013 Oct; 206(1):1-5. PubMed ID: 23948132 [TBL] [Abstract][Full Text] [Related]
14. Ursolic acid from Oldenlandia diffusa induces apoptosis via activation of caspases and phosphorylation of glycogen synthase kinase 3 beta in SK-OV-3 ovarian cancer cells. Song YH; Jeong SJ; Kwon HY; Kim B; Kim SH; Yoo DY Biol Pharm Bull; 2012; 35(7):1022-8. PubMed ID: 22791147 [TBL] [Abstract][Full Text] [Related]
16. Discovery of new GSK-3β inhibitors through structure-based virtual screening. Dou X; Jiang L; Wang Y; Jin H; Liu Z; Zhang L Bioorg Med Chem Lett; 2018 Jan; 28(2):160-166. PubMed ID: 29208522 [TBL] [Abstract][Full Text] [Related]
17. From a natural product lead to the identification of potent and selective benzofuran-3-yl-(indol-3-yl)maleimides as glycogen synthase kinase 3beta inhibitors that suppress proliferation and survival of pancreatic cancer cells. Gaisina IN; Gallier F; Ougolkov AV; Kim KH; Kurome T; Guo S; Holzle D; Luchini DN; Blond SY; Billadeau DD; Kozikowski AP J Med Chem; 2009 Apr; 52(7):1853-63. PubMed ID: 19338355 [TBL] [Abstract][Full Text] [Related]
18. Structure-Based design of Marine-derived Meridianin C derivatives as glycogen synthase kinase 3β inhibitors with improved oral bioavailability: From aminopyrimidyl-indoles to the sulfonyl analogues. Han S; Zhou W; Zhuang C; Chen F Bioorg Chem; 2022 Feb; 119():105537. PubMed ID: 34902644 [TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis and in Vitro Tumor Cytotoxicity Evaluation of 3,5-Diamino-N-substituted Benzamide Derivatives as Novel GSK-3β Small Molecule Inhibitors. Zhou Y; Zhang L; Fu X; Jiang Z; Tong R; Shi J; Li J; Zhong L Chem Biodivers; 2019 Sep; 16(9):e1900304. PubMed ID: 31338947 [TBL] [Abstract][Full Text] [Related]
20. GSK-3 inhibition overcomes chemoresistance in human breast cancer. Ugolkov A; Gaisina I; Zhang JS; Billadeau DD; White K; Kozikowski A; Jain S; Cristofanilli M; Giles F; O'Halloran T; Cryns VL; Mazar AP Cancer Lett; 2016 Oct; 380(2):384-392. PubMed ID: 27424289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]